Therefore, further investigation into the relationship between aberrant expression of AFAP1‐AS1 and breast cancer progression will enhance our comprehension of the pathogenesis of breast cancer and facilitate identification of more reliable clinical therapeutic targets. Here, AFAP1 is linked to breast cancer.